O

OMX Ventures

15 employees

OMX Ventures is investing at the convergence of biology and computing.

Investor insights

Sectors invested in

Biotechnology11
Life Science4
Health Care4
Therapeutics3
Pharmaceutical2
Medical2
Artificial Intelligence1
Enzyme writing1
Hypo-immunogenic cell therapy1
Genome writing1
Gene therapy1
Gene editing1
Transcriptional regulation1
Protein engineering1
Biopolymers1
Synthetic Biology1
Genome engineering1
Clinical Trials1
Machine Learning1
Proteomics1

Funding rounds participated in

$7.8M sweet spot round size

Most of their 11 investments are in rounds between $8M and $70M

Investor type

Venture Capital

Basic info

Industry

financial services

Date founded

2020

Investments made

L

Lightcast Discovery raised $49M on August 17, 2023

Investors: LONGWALL VENTURE PARTNERS LLP, Illumina Ventures, M Ventures, ARCH Venture Partners and OMX Ventures

C

Constructive Bio raised $15M on August 15, 2022

Investors: Amadeus Capital Partners, General Inception, Ahren Innovation Capital and OMX Ventures

R

Replay raised $55M on July 25, 2022

Investors: SALT Ventures Indonesia, KKR & Co. Inc., ARTIS Ventures and OMX Ventures

M

Mythic Therapeutics, Inc. raised $103M on December 15, 2021

Investors: Lifeforce Capital, First Round Capital, Foresite Capital, Viking Global Investors, Perceptive Advisors, Refactor Capital, Venrock and OMX Ventures

D

Delix Therapeutics raised $70M on September 27, 2021

Investors: re.Mind Capital, Presight Capital, Palo Santo, PsyMed Ventures, -, Saya Bio, RA Capital Management, L.P. and OMX Ventures

G

Glyphic Biotechnologies raised $6M on July 8, 2021

Investors: Civilization Ventures, Cantos Ventures, Osage University Partners (OUP), ARTIS Ventures and OMX Ventures

M

Matterworks raised $6M on December 17, 2020

Investors: Wavemaker Three-Sixty Health, iGlobe Partners, Pillar VC and OMX Ventures

S

Sestina Bio, LLC. raised undisclosed on October 14, 2020

Investors: Foresite Capital, General Inception and OMX Ventures

F

Finch Therapeutics Group raised $90M on September 17, 2020

Investors: Willett Advisors LLC, Trans-Pacific Technology Fund, Octave Ventures LLC, Octave Group, Shumway Capital, The Baupost Group, Susquehanna International Group (SIG), OCV and OMX Ventures

D

Delix Therapeutics raised $8M on September 4, 2020

Investors: Presight Capital and OMX Ventures

FAQ